Merck Kgaa ADR (MKKGY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 858,720 | 3,517,970 | 2,699,296 | 1,866,607 | 992,025 |
| Depreciation Amortization | 489,470 | 2,138,808 | 1,442,310 | 1,023,760 | 482,546 |
| Accounts receivable | -124,514 | -435,137 | -390,794 | -571,475 | -384,915 |
| Accounts payable and accrued liabilities | 230,781 | 106,414 | 197,411 | 294,783 | 232,295 |
| Other Working Capital | -449,755 | -1,139,995 | -841,012 | -1,063,136 | -503,868 |
| Other Operating Activity | -89,092 | 299,222 | 160,145 | 250,087 | 124,564 |
| Operating Cash Flow | $915,610 | $4,487,282 | $3,267,357 | $1,800,626 | $942,648 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -603,251 | 22,126 | -1,058,567 | -709,821 | -463,469 |
| Net Acquisitions | N/A | -632,160 | -701,011 | -739,619 | -779,929 |
| Purchase Of Investment | -23,615 | -1,613,062 | -217,555 | -51,082 | -26,933 |
| Sale Of Investment | 241,515 | 632,160 | 136,979 | 131,961 | 97,631 |
| Purchase Sale Intangibles | -80,505 | -249,703 | -175,253 | -101,099 | -52,743 |
| Other Investing Activity | -936,004 | -1,299,089 | -674,825 | -626,814 | -49,377 |
| Investing Cash Flow | $-1,321,355 | $-2,890,025 | $-2,514,979 | $-1,995,375 | $-1,222,076 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 231,854 | -3,449,486 | 1,986,198 | 1,058,879 | N/A |
| Debt Repayment | -1,073 | 2,829,970 | -2,076,846 | -187,299 | -241,273 |
| Dividend Paid | -96,606 | -1,017,778 | -972,955 | -1,028,017 | -113,342 |
| Other Financing Activity | -1,073 | -1,054 | -1,007 | -1,064 | 1,122 |
| Financing Cash Flow | $133,102 | $-1,638,348 | $-1,064,610 | $-157,502 | $-353,493 |
| Exchange Rate Effect | -17,174 | -7,375 | 15,108 | 11,706 | 4,489 |
| Beginning Cash Position | 1,990,084 | 2,000,786 | 1,912,673 | 2,020,916 | 2,131,058 |
| End Cash Position | 1,700,266 | 1,953,374 | 1,615,549 | 1,681,436 | 1,502,626 |
| Net Cash Flow | $-289,818 | $-47,412 | $-297,124 | $-339,480 | $-628,432 |
| Free Cash Flow | |||||
| Operating Cash Flow | 915,610 | 4,487,282 | 3,267,357 | 1,800,626 | 942,648 |
| Capital Expenditure | -613,985 | N/A | -1,072,668 | -720,463 | -482,546 |
| Free Cash Flow | 301,625 | 4,487,282 | 2,194,689 | 1,080,163 | 460,102 |